31 – 40 of 400
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
- Contribution to journal › Article
-
Mark
Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study
- Contribution to journal › Article
-
Mark
Association between breast cancer risk and disease aggressiveness : Characterizing underlying gene expression patterns
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
- Contribution to journal › Article
-
Mark
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
- Contribution to journal › Article
-
Mark
Sample preparation approach influences pam50 risk of recurrence score in early breast cancer
- Contribution to journal › Article
-
Mark
The spatial RNA integrity number assay for in situ evaluation of transcriptome quality
- Contribution to journal › Article
-
Mark
Molecular analyses of triple-negative breast cancer in the young and elderly
- Contribution to journal › Article
- 2020
-
Mark
Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017
(2020) San Antonio Breast Cancer Symposium, 2019 In Cancer research. Supplement 80(Issue 4 Supplement). p.1-18
- Contribution to journal › Published meeting abstract
-
Mark
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
- Contribution to journal › Article
